These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preventing renal disease progression: is it the drug or the blood pressure reduction, or both? Weir MR Curr Hypertens Rep; 2000 Dec; 2(6):497-9. PubMed ID: 11062593 [No Abstract] [Full Text] [Related]
25. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors]. Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714 [TBL] [Abstract][Full Text] [Related]
26. Dihydropyridine calcium channel blockers and renal disease. Robles NR; Fici F; Grassi G Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800 [TBL] [Abstract][Full Text] [Related]
27. The kidney and strategies for the treatment of hypertension. Hollenberg NK Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease. Ritz E; Orth SR; Strzelczyk P J Hypertens Suppl; 1997 Mar; 15(2):S21-6. PubMed ID: 9218194 [TBL] [Abstract][Full Text] [Related]
29. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney. Thurman JM; Schrier RW Am J Med; 2003 May; 114(7):588-98. PubMed ID: 12753883 [TBL] [Abstract][Full Text] [Related]
31. Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study. Okura T Hypertens Res; 2010 Nov; 33(11):1112-3. PubMed ID: 20811385 [No Abstract] [Full Text] [Related]
32. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]
33. "Proteinuria" itself cannot be taken as a definite marker of improved renal function. Chang LC Nephrol Dial Transplant; 2010 Nov; 25(11):3799; author reply 3799-800. PubMed ID: 20732923 [No Abstract] [Full Text] [Related]
34. [Therapy for hypertension associated with kidney disease]. Suzuki H Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731 [No Abstract] [Full Text] [Related]
35. Calcium antagonists and the kidney. Epstein M J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073 [TBL] [Abstract][Full Text] [Related]
36. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy. Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658 [TBL] [Abstract][Full Text] [Related]